Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.

ABSTRACT:

SUBMITTER: Wu H 

PROVIDER: S-EPMC4987127 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature